Advisory Board

We benefit from the extensive network of our advisors

Dr. Ross Cagan

Scientific Advisory Board

Regius Professor of Precision Medicine and Director of the Center For Personalised Cancer Therapeutics at University of Glasgow. Former Director of the Center for Personalised Cancer Therapeutics at Mount Sinai, New York.

Michael Elashoff

Scientific Advisory Board

Head of Data Science at Project Rōnin. Co-founded a software company that developed novel machine learning / AI methods for clinical trials (acquired by Medidata Solutions). Developed the algorithms behind two validated genomic diagnostic tests.

Dr. Michael Castro

Medical Advisory Board

Neuro & Medical Oncologist, Beverly Hills Cancer Center. Expertise in immunotherapy of cancer and precision medicine. Recognised as one of Top Doctors in America by US News & World Report.

Dr. Mehra Golshan

Medical Advisory Board

Deputy Chief Medical Officer, Director Breast Program, Chief of Breast Surgery, Yale Cancer Center, Smilow Cancer Hospital. Professor of Surgery, Yale School of Medicine.

Dr. Moez Benali

Medical Advisory Board

Medical Director of Oncology-Hematology, Novartis Oncology Region Europe, Paris. Notable expertise in anti-cancer drugs.

Dr. Elizabeth Smyth

Medical Advisory Board

Gastrointestinal Oncology Consultant, Addenbrooke’s Hospital, Cambridge. Research focus on clinical trials and translational research in gastroesophageal cancer. Elected secretary of EORTC GI clinical trials group 2018-2021.

Dr. Jonas Feilchenfeldt

Medical Advisory Board

Consultant in Medical Oncology, core faculty member ESO, Service d’Oncologie Médicale, Riviera-Chablais Hospital, Switzerland. Focus on Gastrointestinal Oncology.

Matthew Scherba

Corporate Advisory Board

Extensive experience in venture capital, supporting the development of deep tech and IoT companies globally.